Skip to main content

stock

EDSA · Edesa Biotech, Inc.

What Edesa Biotech, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live EDSA price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on EDSA.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
9,641,031 as of 2026-08-13 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-160.0%
ROA
-110.9%

Health

Current ratio
2.8x
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$5.52M-$5.41M
10-Q filed 2026-08-13
2026-03-31——Gross profit: unreported by this company.-$4.30M-$4.22M
10-Q filed 2026-05-14
2025-12-31——Gross profit: unreported by this company.-$2.34M-$2.25M
10-Q filed 2026-02-13
2025-09-30——Gross profit: unreported by this company.-$2.47M-$2.23M
10-K filed 2025-12-12
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-06-30——Gross profit: unreported by this company.-$1.90M-$1.75M
10-Q filed 2026-08-13
2025-03-31——Gross profit: unreported by this company.-$1.64M-$1.59M
10-Q filed 2026-05-14
2024-12-31——Gross profit: unreported by this company.-$1.90M-$1.62M
10-Q filed 2026-02-13
2024-09-30——Gross profit: unreported by this company.-$1.00M-$962,051
10-K filed 2025-12-12
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assets
$12.72M
Equity
$8.81M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-09-30—-$7.91M-$7.19M—
2024-09-30—-$7.01M-$6.17M—
2023-09-30—-$9.22M-$8.37M-$6.64M
2022-09-30—-$18.37M-$17.55M-$12.28M
2021-09-30$0-$23.68M-$13.34M-$13.67M
2020-09-30$328,801-$6.40M-$6.36M-$4.99M
2018-12-31$0-$1.62M-$1.54M-$1.30M
2018-09-30$0-$5.08M-$5.04M-$5.00M
2017-09-30$50,000-$5.22M-$5.03M-$5.00M
2016-09-30$1.27M-$4.91M-$5.03M-$4.91M

Company filings

since Thu Jul 2 · 4 offering filings in 12 months · since Thu Aug 20

events

  • Material agreement, Other event

    Material agreementOther event
    Aug 208-K
  • Results

    Results
    Aug 138-K
  • Material agreement, Unregistered share sale, Regulation FD disclosure

    Material agreementUnregistered share saleRegulation FD disclosure
    Jun 118-K
  • Other event

    Other event
    Jun 58-K
  • Executive or director change, Shareholder vote results

    Executive or director changeShareholder vote results
    May 298-K
  • Executive or director change

    Executive or director change
    May 158-K

5% owners ()

  • Stonepine Capital Management, LLC

    Passive stake

    6.9%Aug 26SCHEDULE 13G
  • Pardeep Nijhawan Medicine Professional Corporation

    Stake update

    16.3%Aug 25SCHEDULE 13D/A
  • Velan Capital Master Fund LP

    Stake update

    10.0%Aug 25SCHEDULE 13D/A
  • Integrated Core Strategies (US) LLC

    Passive stake

    5.4%Jun 18SCHEDULE 13G
  • Pardeep Nijhawan Medicine Professional Corporation

    Stake update

    20.0%Jun 16SCHEDULE 13D/A

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named EDSA, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about EDSA.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about EDSA.

nakagai

Signals on EDSA come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the EDSA board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Edesa Biotech, Inc. (EDSA): SEC filings, financials and insider trades · Nakagai